Výsledky vyhledávání

Apoptosis and Cell Growth Inhibition as Antitumor Effector Functions of Interferons

Autor: H Strander, Sangfelt

Publikováno v: Medical Oncology. 18:3-14

Since their introduction to the clinic some 30 yr ago, interferons (IFNs) have become standard therapy for a range of disorders, including malignant and benign tumors as well as various viral diseases. Although IFNs will induce remissions in some pat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98c82609faa086a84cb29336dc79f9f5
https://doi.org/10.1385/mo:18:1:3

Zobrazit plný text záznamu

Correlation between basic fibroblast growth factor immunostaining of stromal cells and stromelysin-3 mRNA expression in human breast carcinoma

Autor: P Byström, Stig Linder, Christina Linder, Gert Auer, U Aspenblad, H Strander, G Engel

Publikováno v: British Journal of Cancer

We examined the localization of basic fibroblast growth factor (bFGF) in a series of human breast carcinomas using immunohistochemistry. Staining was observed in tumour cells in 15 out of 54 (28%) tumours and in the adjacent stroma in 34 out of 54 (6

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b0f8d9335b52990a5eb28be2380a5c
https://doi.org/10.1038/bjc.1998.155

Zobrazit plný text záznamu

Dacarbazine-Vindesine-Cisplatin in Disseminated Malignant Melanoma

Autor: Ulrik Ringborg, Johan Hansson, H. Strander, U. Jungnelius

Publikováno v: American Journal of Clinical Oncology. 13:214-217

Dacarbazine-vindesine-cisplatin treatment was evaluated in a phase II study of patients with disseminated malignant melanoma after the dose of cisplatin had been determined in a phase I study. Dose of dacarbazine was 250 mg/m2 X V every 4 weeks, vind

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27492e8587f3d127925c05be64328f24
https://doi.org/10.1097/00000421-199006000-00007

Zobrazit plný text záznamu

Evaluation of tissue and serum VEGF in patients with head and neck carcinoma

Autor: C, Linder, S, Linder, E, Munck-Wikland, G, Auer, U, Aspenblad, H, Strander

Publikováno v: Angiogenesis. 2(4)

Serum vascular endothelial growth factor (VEGF) was measured in 54 cancer patients with head and neck carcinoma. In addition, tumor VEGF was examined by immunohistochemistry in sections of biopsies obtained within 4 weeks to serum sampling in 37 of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e25952761d1aa4107da13a1459815f78
https://pubmed.ncbi.nlm.nih.gov/14517456

Zobrazit plný text záznamu

Angiostatin fragments in urine from patients with malignant disease

Autor: M, Sten-Linder, C, Linder, H, Strander, E, Munck-Wikland, P, Wersäll, S, Linder, B, Wiman

Publikováno v: Anticancer research. 19(4C)

Angiostatin, a family of fragments originating from the NH2-terminal portion of plasminogen, has been described as a potent inhibitor of angiogenesis. In order to examine to what extent angiostatin can be detected in cancer patients, urine was collec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::577da9085ddce3031a192d6080b699c8
https://pubmed.ncbi.nlm.nih.gov/10629628

Zobrazit plný text záznamu

Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma

Autor: C, Linder, S, Linder, E, Munck-Wikland, H, Strander

Publikováno v: Anticancer research. 18(3B)

Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) were quantified in the sera of 100 patients with sarcoma, head and neck carcinoma, oesophageal carcinoma, mesothelioma and lung carcinoma. VEGF and bFGF levels were g

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8bf86b8bc91e40eb54855c9cfdcc33ff
https://pubmed.ncbi.nlm.nih.gov/9677468

Zobrazit plný text záznamu

Adjuvant interferon treatment in human osteosarcoma

Autor: H, Strander, H C, Bauer, O, Brosjö, A, Kreicbergs, J, Lindholm, U, Nilsonne, C, Silfverswärd, A, Szamosi

Publikováno v: Cancer treatment and research. 62

An update of the adjuvant trial on osteosarcoma in Sweden comparing patients receiving natural interferon (IFN) alpha with a high-dose chemotherapy group and a nonadjuvant group is presented. The overall survival for the IFN group is 49%, for the che

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::37354fce42c99110633e50494571a60a
https://pubmed.ncbi.nlm.nih.gov/8096744

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání